Clarence Peters

Update Your Profile
Profile URL: www.utmb.edu/pathology/profiles/?user=cjpeters
Clarence Peters
Contact Information
Email:

Directory lookup

Academic Appointments
Appointment Organization
Director for Biodefense Center for Biodefense and Emerging Infectious Dise
Professor Pathology
Professional Education
Degree Institution Field of Study Graduation Year
M.D. Johns Hopkins University 1966
A.B. Rice University Chemistry (summa cum laude) 1962
Honors
Title Organization Year(s)
Secretary’s Award, Health and Human Services, (Nipah investigation) 2000
Secretary’s Award, Health and Human Services, (Ebola investigation) 1996
Secretary’s Award, Health and Human Services, (Hantavirus investigation) 1994
"A" Proficiency Designator Award, U.S. Army 1989
Army Science Conference Award 1986
Surgeon General's Award 1981
Sigma Xi -
Phi Lambda Upsilon -
Phi Beta Kappa -
Alpha Omega Alpha -
Army Commendation Medal -
Army Achievement Award -
Legion of Merit -
Professional Affiliations
Society Year(s)
American Committee on Arbovirology; Executive Council 1986
American Committee on Arbovirology; Executive Council 1983 - 1987
American Society for Virology -
American Society for Microbiology -
Infectious Diseases Society of America, Fellow -
American College of Physicians -
American Board of Internal Medicine -
American Society of Tropical Medicine and Hygiene -
American Association of Immunologists -
Research Interests

Virus Disease

My research has focused on the pathogenesis and epidemiology of the viral hemorrhagic fevers and other emerging viral infections. At UTMB I have concentrated on the contributions of basic virology, immunology and structural biology to this field. Most of the current work in the laboratory deals with Bunyaviridae (phleboviruses such as Rift Valley fever), Arenaviridae (Lassa fever, South American hemorrhagic fevers) and SARS CoV.

I am working on the phylogeny of phleboviruses, reassortment of their tripartite genomes and their pathogenecity. The most important Phlebovirus is Rift Valley fever virus and there is an active program of human and animal vaccine development for this agent using reverse genetics. Ilya Frolov and I are developing alphavirus replicon vectored Rift Valley fever vaccines for use in livestock and later humans. Arenavirus research concentrates on the effects of infection on cellular function, particularly those molecular interactions related to vascular permeability. SARS-CoV work includes antiviral drug development, model characterization, and interferon interactions.

There is a BLS-4 laboratory recently opened to allow UTMB scientists to work safely with any agent. We will transition some of the other projects to higher hazard viral hemorrhagic fevers and develop projects on other viruses such as tick-borne flaviviruses, highly virulent avian influenza strains, and Nipah virus, a new, highly virulent paramyxovirus.

Selected Publications
  1. Qian, C., Z.M. Guo, C. J. Peters, and C.T. Liu. 1993. Platelet activating factor (PAF)-induced cardiopulmonary dysfunctions and their reversal with a PAF antagonist (BN 52021) in strain 13 guinea pigs. J Lipid Mediators 7:223-237
  2. *Morikawa, et al. Enzyme linked immunosorbent assays for detection of antibodies to Ebola and Marburg viruses using recombinant nucleoproteins, J Clin Micro, 2001
  3. *Woods CW, AM Karpati, T Grein, N McCarthy, P Gaturuku, E Muchiri, L Dunster, A Henderson, AS Khan, R Swanepoel, I Bonmarin, B Smoak, L Martin, P Mann, M Ryan, TG Ksiazek, RR Arthur, NN Agata, CJ Peters and the WHO Hemorrhagic Fever Task Force. An outbreak of Rift Valley fever in northeastern Kenya, 1997-98. Sub for pub, 2001
  4. Mahanty, S, D Bausch, RL Thomas, A Goba, A Bah, CJ Peters, PE Rollin. Low levels of IL-8 and IP-10 in serum are associated with fatal infections in acute Lassa fever. ] Journal of Infectious Diseases. 183(12):1713-21, 2001
  5. CDC. Outbreak of Rift Valley fever -- Saudi Arabia, August-October 2000. MMWR, 2000;49:905-908
  6. Chua, KB, WJ Bellini, PA Rota, BH Harcourt, A Temin, SK Lam, TG Ksiazek, P Rollin, SR Zaki, W-J Shieh, CS Goldsmith, JT Roehrig, B Eaton, R Gould, J Olson, H Field, P Daniel, AE Ling, CJ Peters, LJ Anderson, BWJ Mahy. Nipah Virus: A Recently Emergent Deadly Paramyxovirus. Science, 288:1432-1435, 2000
  7. CDC. Fatal Illnesses Associated with a New World Arenavirus—California, 1999-2000. MMWR, 2000;49:709-711
  8. Williams RJ, Al-Busaidy S, Mehta FR, Maupin GO, Wagoner KD, Al-Awaidy S, Suleiman AJM, Khan AS, Peters CJ, Ksiazek TG. Crimean-Congo haemorrhagic fever: a seroepidemiological and tick survey in the Sultanate of Oman. Tropical Medicine & International Health 2000;5(2):99-106
  9. Hutchinson KL. Rollin PE. Shieh WJ. Zaki S. Greer PW. Peters CJ. Transmission of Black Creek Canal virus between cotton rats. J Med Virol. 60(1):70-6, 2000
  10. Bausch DG, Rollin PE, Demby AH, Coulibaly M, Kanu J, Conteh AS, Wagoner KD, McMullan LK, Bowen MD, Peters CJ, and TG Ksiazek. Diagnosis and Clinical Virology of Lassa Fever as Evaluated by Enzyme-Linked Immunosorbent Assay, Indirect Fluorescent-Antibody Test, and Virus Isolation. Journal of Clinical Microbiology 2000;38:2670-2677
  11. Vincent MJ. Quiroz E. Gracia F. Sanchez AJ. Ksiazek TG. Kitsutani PT. Ruedas LA. Tinnin DS. Caceres L. Garcia A. Rollin PE. Mills JN. Peters CJ. Nichol ST. Hantavirus pulmonary syndrome in Panama: Identification of novel Hantaviruses and their likely reservoirs. Virology. 277(1):14-19, 2000
  12. CDC. Update: Outbreak of Rift Valley Fever – Saudi Arabia, August-November 2000. MMWR, 2000;49:982-985
  13. Glass, GE, JE Cheek, JA Patz, TM Shields, TJ Doyle, DA Thoroughman, DK Hunt, RE Enscore, KL Gage, C Irland, CJ Peters, R Bryan. Using Remotely Sensed Data To Identify Areas at Risk for Hantavirus Pulmonary Syndrome EID, 2000;6:238-247
  14. Chin C. Chiueh TS. Yang WC. Yang TH. Shih CM. Lin HT. Lin KC. Lien JC.Tsai TF. Ruo SL. Nichol ST. Ksiazek TG. Rollin PE. Peters CJ. Wu TN. Shen CY. Hantavirus infection in Taiwan: the experience of a geographically unique area. Journal of Medical Virology. 60(2):237-47, 2000
  15. Bowen MD. Rollin PE. Ksiazek TG. Hustad HL. Bausch DG. Demby AH. Bajani MD. Peters CJ. Nichol ST. Genetic diversity among Lassa virus strains. Journal of Virology. 74(15):6992-7004, 2000
  16. Rollin PE, J Williams, D Bressler, S Pearson, M Cottingham, G Pucak, A Sanchez, SJ Trappier, RL Peters, PW Greer, S Zaki, T Demarcus, K Hendricks, M Kelley, D Simpson, TW Geisbert, PB Jahrling, CJ Peters, TG Ksiazek. Ebola (Subtype Reston) Virus among Quarantined Nonhuman Primates Recently Imported from the Philippines to the United States. J Infect Dis, 1999;179 (Supp l):S108-114
  17. Linthicum KJ, Anyamba A, Tucker CJ, Kelley PW, Myers MF, Peters CJ. Climate and satellite indicators to forecast Rift Valley fever epidemics in Kenya. Science 1999;285:397-400
  18. Update: Hantavirus Pulmonary Syndrome – United States, 1999. MMWR 1999;48(no.24):521-555
  19. Mills JN, Ksiazek TG, Peters CJ, Childs JE. Long-term studies of hantavirus reservoir populations in the southwestern US: a synthesis. EID. 1999;5:135-142
  20. Fulhorst CF. Bowen MD. Salas RA. Duno G. Utrera A. Ksiazek TG. DeManzione NM. De Miller E. Vasquez C. Peters CJ. Tesh RB. Natural rodent host associations of Guanarito and Pirital viruses (Family Arenaviridae) in central Venezuela. Amer J Trop Med Hyg. 61(2):325-30, 1999
  21. Bwaka, MA, M-J Bonnet, P Calain, R Colebunders, A De Roo, Y Guimard, KR Katwiki, KK Kibadi, MA Kipasa, KJ Kuvula, BB Mapanda ,M Massamba ,KD Mupapa, J-J Muyembe, E Ndaberey, CJ Peters, et al. Ebola Hemorrhagic Fever in Kikwit, Democratic Republic of the Congo (former Zaire): Clinical Observations in Dis, 1999;179 (Supp l):S1-7
  22. Jahrling, PB, TW Geisbert, JB Geisbert, JR Swearengen, M Bray, NK Jaax, JW Huggins, JW LeDuc, and CJ Peters. Evaluation of Immune Globulin and Recombinant Interferon alpha-2b for Treatment of Experimental Ebola Virus Infections. J Infect Dis, 1999;179 (Supp l):S224-234
  23. Maruyama, T, P Parren, A Sanchez, I Rensink, LL Rodriguez, AS Khan, CJ Peters, and DR Burton. Recombinant Human Monoclonal Antibodies to Ebola Virus. J Infect Dis, 1999;179 (Supp l):S235-239
  24. CDC. Update. 1999. Outbreak of Nipah virus--Malaysia and Singapore, 1999. MMWR Morbidity Mortality Weekly Report. 48(16)335-337
  25. Lloyd, ES, SR Zaki, PE Rollin, K Tchioko, MA Bwaka, TG Ksiazek, P Calain, S Wun-Ju, MK Kondé, E Verchueren, HN Perry, VM Lubaki, JK Kabwau, R Ndambi, and CJ Peters. Long-Term Disease Surveillance in Bandundu Region, Democratic Republic of the Congo (former Zaire): A Model for Early Detection and Prevention of Ebola Hemorrhagic Fever. J Infect Dis, 1999;179 (Supp l):S274-280
  26. Ksiazek, TG, CP West, PE Rollin, PB Jahrling, and CJ Peters. Enzyme-Linked Immunosorbent Assays for the Detection of Antibodies to Ebola Viruses. J Infect Dis, 1999;179 (Supp l):S192-198
  27. Leirs, H, JN Mills, JW Krebs, JE Childs, D Akaibe, N Woollen, GE Ludwig, CJ Peters, and TG Ksiazek. Search for the Ebola-Reservoir in Kikwit: Reflections on the Vertebrate Collection. J Infect Dis, 1999;179 (Supp l):S155-163
  28. Monroe MC, SP Morzunov, AM Johnson, MD Bowen, H Artsob, T Yates, CJ Peters, PE Rollin, TG Ksiazek, ST Nichol. Genetic diversity and distribution of Peromyscus-borne hantaviruses in North America. EID. 1999;5:75-85
  29. Mills JN, Yates TL, Ksiazek TG, Peters CJ, Childs JE. Long-term studies of hantavirus reservoir populations in the southwestern US: rationale, potential, and methods. EID. 1999;5:95-101
  30. Howard MJ. Doyle TJ. Koster FT. Zaki SR. Khan AS. Petersen EA. Peters CJ. Bryan RT. Hantavirus pulmonary syndrome in pregnancy. Clinical Infectious Diseases. 29(6):1538-44, 1999
  31. Harrison LH. Halsey NA. McKee KT Jr. Peters CJ. Barrera Oro JG. Briggiler AM. Feuillade MR. Maiztegui JI. Clinical case definitions for Argentine hemorrhagic fever. Clinical Infectious Diseases. 28(5):1091-4, 1999
  32. Armstrong, LR, LM Dembry, PM Rainey, MB Russi, AS Khan, SH Fischer, SC Edberg, TG Ksiazek, PE Rollin, CJ Peters. Management of a Sabia virus-infected patient in a US hospital. Infect Control and Hosp Epidemiol. 1999;20:176-182
  33. Sanchez, A, TG Ksiazek, PE Rollin, MEG Miranda, SG Trappier, AS Khan, CJ Peters, and ST Nichol. Detection and Molecular Characterization of Ebola Viruses Causing Disease in Human and Nonhuman Primates. J Infect Dis, 1999;179 (Supp l):S164-169
  34. Rowe, AK, J Bertoloi, AS Khan, R Mukunu, JJ Muyembe-Tamfum, D Bressler, AJ Williams, CJ Peters, L Rodriguez, H Feldman, ST Nichol, PE Rollin, TG Ksiazek, for the Commission. Clinical, Virologic, and Immunologic Follow-up of Convalescent Ebola Hemorrhagic Fever Patients and Their Household Contacts, Kikwit, Democratic Republic of Congo. J Infect Dis, 1999;179 (Supp l):S28-35
  35. Villinger, F, PE Rollin, SS Brar, NF Chikkala, J Winter, JB Sundstrom, SR Zaki, R Swanepoel, AA Ansari, and CJ Peters. Markedly Elevated Levels of Interferon (IFN)-gamma, IFN-alpha, Interleukin (IL)-2, IL-10, and Tumor Necrosis Factor-alpha Associated with Fatal Ebola Virus Infection. J Infect Dis, 1999;179 (Supp l):S188-191
  36. Maruyama T. Rodriguez LL. Jahrling PB. Sanchez A. Khan AS. Nichol ST Peters CJ. Parren PW. Burton DR. Ebola virus can be effectively neutralized by antibody produced in natural human infection. J Virol. 73(7):6024-30, 1999
  37. Zaki, S, W-J Sheieh, PW Greer, CS Goldsmith, T Ferebee, J Katshitshi, FK Tshioko, MA Bwaka, R Swanepoel, P Calain, AS Khan, E Lloyd, P Rollin, TG Ksiazek, CJ Peters. A novel immunohistochemical assay for the detection of Ebola virus in skin: implications for diagnosis, spread, and surveillance of Ebola hemorrhagic fever. J Infect Dis, 1999;179 (Supp l):S36-47
  38. Fulhorst CF. Ksiazek TG. Peters CJ. Tesh RB. Experimental infection of the cane mouse Zygodontomys brevicauda (family Muridae) with guanarito virus (Arenaviridae), the etiologic agent of Venezuelan hemorrhagic fever. J Infect Dis. 180(4):966-9, 1999
  39. Pittman PR. Liu CT. Cannon TL. Makuch RS. Mangiafico JA. Gibbs PH. Peters CJ Immunogenicity of an inactivated Rift Valley fever vaccine in humans: a 12-year Vaccine. 18(1-2):181-9, 1999
  40. Chapman LE, Mertz GJ, Peters CJ, Jolson HM, Khan AS, Ksiazek TG, Koster FT, Baum KF, Rollin PE, Pavia AT, Holman RC, Christenson JC, Rubin PJ, Behrman RE, Wilson Bell LJ, Simpson GL, Sadek RF, and the Ribavirin Study Group. Intravenous Ribavirin for Hantavirus Pulmonary Syndrome: Safety and Tolerance During One Year of Open Label Experience. Antiviral Therapy 1999; 4:211-219
  41. Johnson, AM, LTM deSouza, IB Ferreira, LE Pereira, TG Ksiazek, PE Rollin, CJ Peters, ST Nichol. Genetic investigation of novel hantaviruses causing fatal HPS in Brazil. J Med Virol, 59(4):527-35, 1999
  42. Kitsutani PT. Denton RW. Fritz CL. Murray RA. Todd RL. Pape WJ. Wyatt F J. Young JC. Khan AS. Peters CJ. Ksiazek TG. Acute Sin Nombre hantavirus infection without pulmonary syndrome, United States. Emerging Infectious Diseases. 5(5):701-5, 1999
  43. Wells RM, Sosa Estani S, Yadon ZE, Enria D, Padula P, Pini N, Della Valle MG, Mills JN, Peters CJ. Seroprevalence of antibodies to hantavirus in health care workers and other residents of southern Argentina, CID 1998;27:895-6
  44. CDC Infection Control for Viral Hemorrhagic Fevers in the African Health Care Setting 1998
  45. Ravkov EV. Nichol ST. Peters CJ. Compans RW Role of actin microfilaments in Black Creek Canal virus morphogenesis. Journal of Virology. 72(4):2865-70, 1998
  46. Glass, GE, W Livingstone, JN Mills, WG Hlady, JB Fine, W Biggler, T Coke, D Frazier, S Atherley, PE Rollin, TG Ksiazek, CJ Peters, JE Childs. Black Creek Canal virus infection in Sigmodon hispidus in southern Florida. Am J Trop Med Hyg 1998;59:699-703
  47. de Manzione N, Salas RA, Paredes H, Godoy O, Rojas L, Araoz F, Fulhorst CF, Ksiazek TG, Mills JN, Ellis BA, Peters CJ, Tesh RB. Venezuelan Hemorrhagic Fever: clinical and epidemiologic studies of 165 cases. Clinical Infectious Diseases. 1998;26:308-313
  48. Johnson AM, Bowen MD, Ksiazek TG, Williams RJ, Bryan RT, Mills JN, Peters CJ, Nichol ST. Laguna Negra virus associated with HPS in western Paraguay and Bolivia. Virology 1998;238:115-127
  49. Morzunov SP, Rowe JE, Ksiazek TG, Peters CJ, St Jeor SC, Nichol ST. Genetic analysis of the diversity and origin of hantaviruses in Peromyscus leucopus mice in North America. J Virol 1998;72:57-64
  50. Maiztegui JI, McKee KT, Barrera Oro JG, Harrison LH, Gibbs PH, Feuillade MR, Enria DA, Briggiler AM, Levis SC, Ambrosio AM, Halsey NA, Peters CJ and the AHF Study Group. Protective efficacy of a live attenuated vaccine against Argentine hemorrhagic fever, J Infect Dis, 1998;177:277-283
  51. Chapparo J, Vega J, Terry W, Barra B, Meyer R, Peters CJ, Khan AS, Ksiazek TG. Assessment of person-to-person transmission of hantavirus pulmonary syndrome in a Chilean hospital setting. Journal of Hospital Infection 1998;40:281-5
  52. Hutchinson KL; Rollin PE, and Peters CJ. Pathogenesis of a North American hantavirus, Black Creek Canal virus, in experimentally infected Sigmodon hispidus. American Journal of Tropical Medicine and Hygiene. 1998;59:58-65
  53. CDC, Outbreak of Hendra-like virus – Malaysia and Singapore, 1998-1999. MMWR. 1999;48:265-269
  54. Liu CT, Guo ZM, Jahrling PB, Peters CJ. Significance of hemodynamic changes in four cardiac chambers of guinea pigs infected with Pichinde virus. Pathophysiology. 1998;5:91-98
  55. Rodriguez LL, Owens JH, Peters CJ, Nichol, ST. Genetic reassortment among viruses causing hantavirus pulmonary syndrome. Virology. 1998; 242:99-106
  56. Sanchez A. Yang ZY. Xu L. Nabel GJ. Crews T. Peters Biochemical analysis of the secreted and virion glycoproteins of Ebola virus. J Virol 72(8):6442-7, 1998
  57. Mills, JN, Johnson JM, Ksiazek TG, Ellis BA, Rollin PE, Yates TL, Mann MO, Johnson MR, Campbell ML, Miyashiro J, Patrick M, Zyzak M, Lavender D, Novak MG, Schmidt K, Peters CJ, Childs JE. A survey of hantavirus antibody in small-mammal populations in selected U.S. national parks. Amer J Trop Med Hyg, 58(4):525-32, 1998
  58. Hantavirus Pulmonary Syndrome - Colorado and New Mexico, 1998. MMWR, 1998;47:449-452
  59. Williams RJ, Bryan RT, Mills JN, Palma RE, Vera I, Velasquez F, Baez EM, Schmidt WE, Figueroa RE, Peters CJ, Zaki SR, Khan AS, Ksiazek TG. An Outbreak of Hantavirus Pulmonary Syndrome in Western Paraguay. Amer J Trop Med Hyg, 1997;57:274-282
  60. Wells RM, Sosa Estani S, Yadon ZE, Enria D, Padula P, Pini N, Mills JN, Peters CJ, Segura EL, and the Hantavirus Pulmonary Syndrome Study Group for Patagonia. An unusual hantavirus outbreak in southern Argentina: Person-to-person transmission? Emerg Infect Dis 1997;3:171-174
  61. Vasconcelos MI. Lima VP. Iversson LB. Rosa MD. da Rosa AP. da Rosa ES. Pereira LE. Nassar E. Katz G. Matida LH. Zaparoli MA. Ferreira JJ. Peters CJ Hantavirus pulmonary syndrome in the rural area of Juquitiba, Sao Paulo metropolitan area, Brazil [letter]. Revista do Instituto de Medicina Tropical de Sao Paulo. 39(4):237-8, 1997
  62. Rodriguez LL, Maupin GO, Ksiazek TG, Rollin PE, Khan AS, Schwarz TF, Lofts RS, Smith JF, Noor AM, Peters CJ, Nichol ST. Molecular investigation of a multisource outbreak of Crimean-Congo hemorrhagic fever in the United Arab Emirates. Am J Trop Med Hyg 1997;57:512-518
  63. Bowen MD, Peters CJ, Nichol ST. Phylogenetic analysis of the Arenaviridae: patterns of virus evolution and evidence for cospeciation between arenaviruses and their rodent hosts. Molecular Phylogenetics and Evolution, 1997;8:301-316.
  64. Wells RM, Young J, Williams RJ, Armstrong LR, Busico K, Khan AS, Ksiazek TG, Rollin PE, Zaki SR, Nichol ST, Peters CJ. Hantavirus transmission in the United States. Emerging Infectious Diseases 1997;3:361-365.
  65. Glass GE, Johnson JS, Hodenbach GA, DiSalvo CL, Peters CJ, Childs JE, Mills JN. Experimental evaluation of rodent exclusion methods to reduce hantavirus transmission to humans in rural housing. Am J Trop Med Hyg. 1997;56:359-364
  66. Fulhorst CF, Bowen MD, Salas RA, Nuris MC, de Manzione N, Duno G, Utrera, Ksiazek TG, Peters CJ, Nichol ST, Miller ED, Tovar D, Ramos B, Vasquez C, Tesh RB. Isolation and characterization of Pirital virus, a newly discovered South American arenavirus. Am J Trop Med Hyg 1997;56:548-553
  67. Burt FJ, Swanepoel R, Shieh W-J, Leman PA, Greer PW, Coffield, Rollin PE, Ksiazek TG, Peters CJ, Zaki SR. Immunohistochemical and in situ localization of Crimean-Congo hemorrhagic fever virus in human tissues and pathogenic implications. Arch Pathol Lab Med. 1997;121:839-846
  68. Sexton DJ. Rollin PE. Breitschwerdt EB. Corey GR. Myers SA. Dumais MR. Bowen MD. Goldsmith CS. Zaki SR. Nichol ST. Peters CJ. Ksiazek TG Life-threatening Cache Valley virus infection.New Eng J Med. 336:547-9, 1997
  69. Morrill JC, Mebus CA, Peters CJ. Safety of a mutagen-attenuated Rift Valley fever virus vaccine in fetal and neonatal bovids. AJVR, 1997;58:1110-1114
  70. Morrill JC, Mebus CA, Peters CJ. Safety and efficacy of a mutagen-attenuated Rift Valley fever virus vaccine in cattle. AJVR, 1997;58:1104-1109
  71. Georges-Courbot MC, Sanchez A, Lu C, Baize S, Leroy E, Lansout-Soukate J, Tevi-Benissan C, Georges AJ, Trappier SG, Zaki SR, Swanepoel R, Leman PA, Rollin PE, Peters CJ, Nichol ST, Ksiazek TG. Isolation and Phylogenetic Characterization of Ebola Viruses Causing Different Outbreaks in Gabon. Emerging Infectious Diseases, 1997;3: 59-62
  72. Bajani MD. Tomori O. Rollin PE. Harry TO. Bukbuk ND. Wilson L. Childs JE. Peters CJ. Ksiazek TG. A survey for antibodies to Lassa virus among health workers in Nigeria. Trans Royal Soc Trop Med Hyg 91:379-81, 1997
  73. Kilgore PE, Ksiazek TG, Rollin PE, Mills JN, Villagra MR, Montenegro MJ, Costales MA, Paredes LC, Peters CJ. Treatment of Bolivian hemorrhagic fever with intravenous ribavirin. J Infect Dis 1997;24:718-722
  74. Park JY, Peters CJ, Rollin PE, Ksiazek TG, Gray B, Waites KB, Stephenson CB. Development of an RT-PCR assay for diagnosis of lymphocytic choriomeningitis virus (LCMV) infection and its use in a prospective surveillance study. J Med Virol. 1997;51:107-114
  75. Park JY, Peters CJ, Rollin PE, Ksiazek TG, Katholi CR, Waites KB, Gray B, Maetz HM, Stephenson CB. Age distribution of lymphocytic choriomeningitis virus serum antibody in Birmingham, Alabama: evidence of a decreased risk of infection. Am J Trop Med Hyg. 1997;57:37-41
  76. Ksiazek TG, Nichol ST, Mills JN, Groves MG, Wozniak A, McAdams S, Monroe M, Johnson A, Martin ML, Peters CJ, Rollin PE. Isolation, genetic diversity, and geographic distribution of Bayou virus (Bunyaviridae: Hantavirus). Am J Trop Med Hyg 1997;57:445-448
  77. Mills JN. Ksiazek TG. Ellis BA. Rollin PE. Nichol ST. Yates TL. Gannon WL. Levy CE. Engelthaler DM. Davis T. Tanda DT. Frampton JW. Nichols CR. Peters CJ. Childs JE. Patterns of association with host and habitat: antibody reactive with Sin Nombre virus in small mammals in the major biotic communities of the southwestern United States. American Journal of Tropical Medicine & Hygiene. 56(3):273-84, 1997
  78. Toro, J., Vega, J.D., Khan, A.S., Mills, J.N., Padula, P., Terry, W., Yadon, Z., Valderrama, R., Ellis, B.A., Pavletic, C., Cerda, R., Zaki, S., Lhieh, W-J, Meyer, R., Tapia, M., Mansilla, C., Baro, M., Vergara, J.A., Concha, M., Calderón, G., Enria, D., Peters, C.J., and Ksiazek, T.G. An outbreak of hantavirus pulmonary syndrome, Chile, 1997. Emerging Infectious Diseases, 1998;4:687-694
  79. Ennis FA, Cruz J, Spiropoulou CF, Waite D, Peters CJ, Nichol ST, Kariwa H, Koster FT Hantavirus pulmonary syndrome: CD8+ and CD4+ cytotoxic T lymphocytes to epitopes on Sin Nombre virus nucleocapsid protein isolated during acute illness, Virology. 1997;238:380-390
  80. CDC Rift Valley Fever - East Africa, 1997-1998. MMWR, 1998;47:261-264
  81. Pittman PR, Makuch RS, Mangiafico JA, Cannon TL, Gibbs PH, Peters CJ. Long-term duration of detectable neutralizing antibodies after administration of live-attenuated VEE vaccine and following booster vaccination with inactivated VEE vaccine. Vaccine 1996;14:337-43
  82. Horling J, V Chizhikov, A Lundquist, M Jonsson, L Ivanov, A Dekonenko, B Niklasson, T Dzagurova, CJ Peters, E Tkachenko, S Nichol. Khabarovsk virus: a phylogenetically and serologically distinct Hantavirus isolated from Microtis fortis trapped in far-east Russia. J Gen Virol 1996;77:687-694
  83. Peters CJ, Jahrling PB, Khan AS. Management of patients infected with high-hazard viruses: scientific basis for infection control. Arch Virol 1996; Suppl 11:1-28
  84. Fulhorst CF, Bowen MD, Ksiazek TG, Rollin PE, Nichol ST, Kosoy MY, Peters CJ. Isolation and characterization of Whitewater Arroyo virus, a novel North American arenavirus. Virology 1996;224:114-120
  85. Mills JN, Barrera Oro JG, Bressler DS, Childs JE, Tesh RB, Smith JF, Enria DA, Geisbert TW, McKee KT, Peters CJ, Jahrling PB. Characterization of Oliveros virus, a new member of the Tacaribe complex (Arenaviridae: Arenavirus). Amer J Trop Med Hyg, 1996;54:399-404
  86. Miranda ME, TG Ksiazek, TJ Retuya, AS Khan, A Sanchez, CF Fulhorst, PE Rollin, AB Calaor, DL Manalo, MC Roces, MM Dayrit, and CJ Peters. Epidemiology of Ebola (Reston) Virus in the Philippines, 1996. J Infect Dis, 1999;179 (Supp l):S115-119
  87. Swanepoel R, Leman PA, Burt FJ, Zachariades NA, Braack LEO, Ksiazek TG, Rollin PE, Zaki SR, Peters CJ. Experimental Inoculation of Plants and Animals with Ebola Virus. Emerging Infectious Diseases. 1996;2:321-325
  88. Kosoy MY, Elliott LH, Ksiazek TG, Fulhorst CF, Rollin PE, Childs JE, Mills JN, Maupin GO, Peters CJ. Prevalence of antibodies to arenaviruses in rodents from the southern and western United States: evidence for an arenavirus associated with the genus Neotoma. Am J Trop Med Hyg. 1996;54:570-576
  89. Hutchinson KL. Peters CJ. Nichol ST. Sin Nombre virus mRNA synthesis. Virology. 224(1):139-49, 1996
  90. Bowen MD, Peters CJ, Mills JN, and Nichol ST. Oliveros virus: a novel arenavirus from Argentina. Virology 1996;217:362-366
  91. Antoniadis, A., Stylianakis, A., Papa, A., Alexiou-Daniel, S., Lampropoulos, A., Nichol, S.T., Peters, C.J., and Spiropoulou, C.F. 1996. Direct genetic detection of Dobrava virus in Greek and Albanian haemorrhagic fever with renal syndrome (HFRS) patients. J Infect Dis 174: 407, 1996
  92. Sanchez A, Trappier SG, Mahy BWJ, Peters CJ, Nichol ST. The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing. Proc Natl Acad Sci, USA 1996;93:3602-3607
  93. Jahrling PB, Geisbert J, Sweariengen JR, Jaax GP, Lewis T, Huggins JW, Schmidt JJ, LeDuc JW, Peters CJ. Passive immunization of Ebola virus-infected cynomolgus monkeys with immunoglobulin from hyperimmune horses. Arch Virol 1996; [Supp]11:135-140
  94. *Vitek CR, Breiman RF, Ksiazek TG, Rollin PE, McLaughlin JC, Umland ET, et al. Evidence against person-to-person transmission of hantavirus to health care workers. Clin Infect Dis 1996;22:824-826
  95. Zaki SR, Khan AS, Goodman RA, Armstrong LR, Greer PW, Coffield LM, Ksiazek TG, Rollin PE, Peters CJ, Khabbaz RF. Retrospective diagnosis of hantavirus pulmonary syndrome, 1978-1993. Arch Pathol Lab Med 1996;120:134-139
  96. Bowen MD, Peters CJ, Nichol ST. The phylogeny of New World (Tacaribe complex) arenaviruses. Virology 1996;219:285-290
  97. Vitek CR. Ksiazek TG. Peters CJ. Breiman RF. Evidence against infection with hantaviruses among forest and park workers in the southwestern United States. Clinical Infectious Diseases. 23(2):283-5, 1996
  98. Khan AS, Gaviria M, Rollin PE, Hlady WG, Ksiazek TG, Armstrong LR, Greenman R, Ravkov E, Kolber M, Anapol H, Sfakianaki ED, Nichol ST, Peters CJ, Khabbaz RF. Hantavirus pulmonary syndrome in Florida: association with the newly identified Black Creek Canal Virus. Amer J Med 1996;100:46-48
  99. Reiter P, M Turell, R Coleman, B Miller, G Maupin, J Liz, A Kuehne, J Barth, J Geisbert, D Dohm, J Glick, J Pecor, R Robbins, P Jahrling, C Peters, and T Ksiazek. Field Investigations of an Outbreak of Ebola Hemmorrhagic Fever, Kikwit, Zaire, 1995. Arthropod Studies. J Infect Dis, 1999;179 (Supp l):S148-154
  100. Rodriguez, L, A De Roo, Y Guimard, SG Trappier, A Sanchez, D Bressler, AJ Williams, AK Rowe, J Bertolli, A S Khan, TG Ksiazek, CJ Peters, and ST Nichol. Persistence and Genetic Stability of Ebola Virus during the Outbreak in Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis, 1999;179 (Supp l):S170-176
  101. Centers for Disease Control: Outbreak of Ebola viral hemorrhagic fever--Zaire, 1995. MMWR 1995; 44:381-382
  102. Roels, TH, AS Bloom, J Buffington, GL Muhungu, WR MacKenzie, AS Khan, R Ndambi, DL Noah, HR Rolka, CJ Peters, and TG Ksiazek. Ebola Hemorrhagic Fever, Kikwit, Democratic Republic of the Congo, 1995: Risk Factors for Patients without a Reported Exposure. J Infect Dis, 1999;179 (Supp l):S92-97
  103. Dowell, SF, R Mukunu, TG Ksiazek, AS Khan, PE Rollin, C J Peters, and the EHF Study Group. Transmission of Ebola Hemorrhagic Fever: A Study of Risk Factors in Family Members, Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis, 1999;179 (Supp l):S87-91
  104. Busico, KM, KL Marshall, TG Ksiazek, TH Roels, Y Fleerackers, H Feldmann, AS Khan, and CJ Peters. Prevalence of IgG Antibodies to Ebola Virus in Individuals during an Ebola Outbreak, Zaire, 1995. J Infect Dis, 1999;179 (Supp l):S102-107
  105. Ksiazek, TG, PE Rollin, AJ Willliams, DS Bressler, ML Martin, R Swanepoel, FJ Burt, PA Leman, AS Khan, AK Rowe, R Mukumu, A Sanchez, CJ Peters. Clinical virology of Ebola hemorrhagic fever (EHF): Virus, virus antigen , and IgG and IgM antibody findings among EHF patients in Kikwit, Democratic Republic of Congo, 1995. J Infect Dis, 1999;179 (Supp l):S177-187
  106. Khan, AS, TF Kweteminga, DL Heymann, B LeGuenno, P Nabeth, B Kerstiens, Y Freerackers, PH Kilmarx, GR Rodier, O Nkuku, PE Rollin, A Sanchez, SR Zaki, R Swanepoel, O Tomori, ST Nichol, CJ Peters, JJ Muyembe Tamfun, TG Ksiazek. The Reemergence of Ebola Hemorrhagic Fever, Zaire, 1995. J Infect Dis, 1999;179 (Supp l):S76-86
  107. (Mills JN, Childs JE, Ksiazek TG, Peters CJ, Velleca WM) Methods for trapping and sampling small mammals for virologic testing. Centers for Disease Control and Prevention, Atlanta, 1995
  108. Mills, J.N., Yates, T.L., Childs, J.E., Parmenter, R.R., Ksiazek, T.G, Rollin, P.E., Peters, C.J. Guidelines for working with rodents potentially infected with hantavirus. Journal of Mammalogy 1995;76(3):716-722
  109. Rollin, PE, TG Ksiazek, LH Elliott, E Ravkov, M. L. Martin, S. Morzunov, W Livingstone, M Monroe, G Glass, S Ruo, AS Khan, JE Childs, ST Nichol, and CJ Peters 1995 Isolation of Black Creek Canal virus, a new hantavirus from Sigmodon hispidus in Florida. J. Med Virol, 46:35-39
  110. Zaki, SR, PW Greer, LM Coffield, CS Goldsmith, KB Nolte, K Foucar, RM Feddersen, RE Zumwalt GL Miller, AS Khan, PE Rollin, TG Ksiazek, ST Nichol, BWJ Mahy, CJ Peters. Hantavirus pulmonary syndrome: pathogenesis of an emerging infectious disease. Amer J Pathol 1995 146:552-579
  111. Childs JE, Krebs JW, Ksiazek TG, Maupin GO, Gage KL, Rollin PE, Zeitz PS, Sarisky J, Enscore RE, Butler JC, Cheek JE, Glass GE, and Peters CJ. A household-based, case-control study of environmental factors associated with hantavirus pulmonary syndrome in the southwestern United States. Amer J Trop Med Hyg. 1995;52:393-397
  112. Schwarz, TF, SR Zaki, S Morzunov, CJ Peters, ST Nichol. Detection and sequence confirmation of Sin Nombre virus RNA in paraffin-embedded human lung tissues using one-step RT-PCR. J Virol Methods 1995;51:349-356
  113. Ravkov, EV, PE Rollin, TG Ksiazek, CJ Peters, ST Nichol. Genetic and serologic analysis of Black Creek Canal virus and its association with human disease and Sigmodon hispidus infection. Virology 1995;210:482-489
  114. Moolenaar RL, Dalton C, Lipman HB, Umland ET, Gallaher M, Duchin JS, Chapman L, Zaki SR, Ksiazek TG, Rollin PE, Nichol ST, Cheek JE, Butler JC, Breiman RF. Clinical Features That Differentiate Hantavirus Pulmonary Syndrome from Three Other Acute Respiratory Illnesses. Clin Infect Dis 1995;21:643-9
  115. Khan AS, Ksiazek TG, Zaki SR, Nichol ST, Rollin PE, Peters CJ, Khabbaz RF, Cheek JE, Shireley LA, McDonough SL, Welty TK, Kuklinski D. Fatal hantavirus pulmonary syndrome in an adolescent. Pediatrics 1995;95(2):276- 280
  116. Bowen MD. Kariwa H. Rollin PE. Peters CJ. Nichol ST. Genetic characterization of a human isolate of Puumala hantavirus from France. Virus Research. 38:279-89, 1995
  117. Khabbaz, R.F., C.J.Peters, R.L.Berkelman. Hantavirus: responding to emerging infectious diseases. Current Issues in Public Health. 1995;1:10-15
  118. Henderson WW, Monroe MC, St Jeor SC, Thayer WP, Rowe JE, Peters CJ, Nichol ST. Naturally occurring Sin Nombre virus genetic reassortants. Virology 1995;214:602-610
  119. Tomori, O, J Bertolli, PE Rollin, Y Fleerackers, Y Guimard, A De Roo, H Feldmann, F Burt, R Swanepoel, S Killian, AS Khan, K Tchioko, M Bwaka, R Ndambe, CJ Peters, and TG Ksiazek. Serological Survey Among Hospital and Health Center Workers during the Ebola Hemorrhagic Fever Outbreak in Kikwit, Zaire, 1995. J Infect Dis, 1999;179 (Supp l):S98-101
  120. Sadek, RS, AS. Khan, G Stevens, C J Peters, and TG Ksiazek. Ebola Hemorrhagic Fever, Democratic Republic of Congo, 1995: Determinants of Survival. J Infect Dis, 1999;179 (Supp l):S24-27
  121. Morzunov, SP, H Feldmann, CF Spiropoulou, VA Semenova, PE Rollin, TG Ksiazek, CJ Peters, and ST Nichol. 1995. A newly recognized virus associated with a fatal case of hantavirus pulmonary syndrome in Louisiana. J Virol 69:1980-1983
  122. Zeitz PS, JC Butler, JE Cheek, MC Samuel, JE Childs, LA Shands, RE Turner, RE Voorhees, J Sroisky, PE Rollin, TG Ksiazek, L Chapman, SE Reef, KK Komatsu, C Dalton, JW Krebs, GO Maupin, CM Sewell, RF Breiman, CJ Peters. A case-control study of hantavirus pulmonary syndrome during an outbreak in the southwestern United States. J Infect Dis 1995;171:864-870
  123. Ksiazek, T.G., C.J. Peters, P.E. Rollin, S. Zaki, S. Nichol, C. Spiropoulou, S. Morzunov, H. Feldmann, A.Sanchez, A.S. Khan, B.W.J. Mahy, K. Wachsmuth, and J.C. Butler. Identification of a new North American hantavirus that causes acute pulmonary insufficiency. Am J Trop Med Hyg 1995;52:117-123
  124. Pilaski, J, H Feldmann, S Morzunov, PE Rollin, SL Ruo, B Lauer, CJ Peters, ST Nichol. 1995 Genetic identification of a new Puumala vrius strain causing severe hemorrhagic fever with renal syndrome in Germany. J Infect Dis 170:1456-1462
  125. Chizhikov VE, Spiropoulou CF, Morzunov SP, Monroe MC, Peters CJ, Nichol ST. Complete genetic characterization and analysis of isolation of Sin Nombre virus. J Virol 1995;69:8132-8136
  126. Kilgore PE, Peters CJ, Mills JN, Rollin PE, Armstrong L, Khan AS, Ksiazek TG. Prospects for the control of Bolivian hemorrhagic fever. Emerging Infectious Diseases 1995;1:97-100.
  127. Barry M, Russi M, Armstrong L, Geller D, Tesh R, Dembry L, Gonzalez JP, Khan AS, Peters CJ. Treatment of a laboratory-acquired Sabia virus infection. New Eng J Med 1995;333:294-296
  128. Rollin PE. Bowen MD. Kariwa H. Saluzzo JF. Guerard S. Flechaire A. Coudrier D. Sureau P. Peters CJ. Nichol ST. Short report: isolation and partial characterization of a Puumala virus from a human case of nephropathia epidemica in Amer Trop Med Hyg. 52:577-8, 1995
  129. Zaki SR, Shieh W-J, and the Epidemic Working Group. Leptospirosis associated with outbreak of acute febrile illness and pulmonary haemorrhage, Nicaragua, 1995. Lancet (letter) 1996;347:535-536
  130. Muyembe T, Kipasa M for the International Scientific and Technical Committee and WHO Collaborating Centre for Hemorrhagic Fevers. Ebola haemorrhagic fever in Kikwit, Zaire (Correspondence). Lancet 1995;345:1448
  131. Jaax N, Jahrling P, Geisbert J, Steele K, McKee K, Negley D, Johnson E, Jaax G, Peters C. Transmission of Ebola virus (Zaire strain) to uninfected control monkeys in a biocontainment laboratory. Lancet 1995;346:1669-1671
  132. Mills JN, Childs JE, Ksiazek TG, Peters CJ, Velleca WM. Methods for trapping and sampling small mammals for virologic testing. US Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, Atlanta, GA, 1995, 61 pages
  133. Armstrong LA, Bryan RT, Sarisky J, Khan AS, Rowe T, Ettestadt P, Cheek JE, Peters CJ, Rollin PE, Martin ML, Ksiazek TG. Mild hantaviral disease caused by Sin Nombre virus in a four-year-old child. Pediatr Infect Dis J. 1995; 14: 1108-1110
  134. Khan AS, Ksiazek TG, Cheek JE, Shireley LA, Zaki SR, Welty TK, Nichol ST, Kuklinski D, Rollin PE, McDonough SL, Peters CJ, Khabbaz RF. Fatal hantavirus pulmonary syndrome in an adolescent. Pediatrics 1995;95(2):276- 280.
  135. Goldsmith CS, Elliott LH, Peters CJ, Zaki SR. Ultrastructural characteristics of Sin Nombre virus, causative agent of hantavirus pulmonary syndrome. Arch Virol 1995;140:2107-2122
  136. *Chu Y-K, Jennings G, Schmaljohn A, Elgh F, Hjelle B, Lee HW, Jenison S. Ksiazek T. Peters CJ. Rollin P. et al.. Cross-neutralization of hantaviruses from immune serum from experimentally-infected animals and from hemorrhagic fever with renal syndrome and hantavirus pulmonary syndrome patients. J Infect Dis 1995;172:1581-1584
  137. Khan AS, Ksiazek TG, Cheek JE, Shireley LA, Zaki SR, Welty TK, Nichol ST, Kuklinski D, Rollin PE, McDonough SL, Peters CJ, Khabbaz RF. Fatal hantavirus pulmonary syndrome in an adolescent. Pediatrics 1995;95(2):276- 280
  138. Armstrong LR, Zaki SR, Goldoft MJ, Todd RL, Khan AS, Khabbaz RF, Ksiazek TG, Peters CJ. Hantavirus pulmonary syndrome associated with entering or cleaning rarely used, rodent-infested structures. J Inf Dis 1995;172:1166
  139. Elliott, Luanne H.; Ksiazek, Thomas G.; Rollin, Pierre E.; Spiropoulou, Christina F.; Morzunov, Sergey; Monroe, Marty; Goldsmith, Cynthia S.; Humphrey, Charles D.; Zaki, Sherif R.; Krebs, John W.; Maupin, Gary; Gage, Kenneth; Childs, Jaimie E.; Nichol, Stuart T.; Peters, Clarence J. Isolation of the causative agent of hantavirus pulmonary syndrome. American Journal of Tropical Medicine and Hygiene. 1994; 51(1): 102-108
  140. Wilson ML. Chapman LE. Hall DB. Dykstra EA. Ba K. Zeller HG. Traore-Lamizana M. Hervy JP. Linthicum KJ. Peters CJ Rift Valley fever in rural northern Senegal: human risk factors and potential vectors. American Journal of Tropical Medicine & Hygiene. 50(6):663-75, 1994
  141. Kenyon, R.H., B. Niklasson, P.J. Jahrling, T. Geisbert, L. Svensson, A. Fryden, M. Bengtsson, U. Foberg, C.J. Peters. Virologic investigation of a case of suspected hemorrhagic fever. Res Virol, 1994; 145:397-406.
  142. Richmond, J.Y., C.A. Dykewicz, L.M. Alderman, C.J.Peters. Working safely with LCMV-infected immunocompromised animals. Lab Animal, 1994;25-28
  143. Khan AS, Maupin GO, Rollin PE, Noor AM, Shurie HHM, Shalabi AGA, Wasef S, Haddad YMA, Sadek R, Ijaz K, Peters CJ, Ksiazek TG. An outbreak of Crimean-Congo hemorrhagic fever in the United Arab Emirates, 1994-1995. Am J Trop Med Hyg 1997;57:519-25
  144. Duchin J.S, Koster FT, Peters CJ, Simpson GL, Tempest B, Zaki SR, Ksiazek TG, Rollin PE, Nichol S, Umland ET, Moolenaar RL, Reef SE, Nolte KB, Gallaher MM, Butler JC, Breiman RF, and the Hantavirus Study Group. Hantavirus pulmonary syndrome: a clinical description of 17 patients with a newly recognized disease. N Engl J Med 1994; 330:949-55
  145. Qian, C, PB Jahrling, CJ Peters, CT Liu. 1994. Cardiovascular and pulmonary responses to Pichinde virus infection in strain 13 guinea pigs, Lab Animal Sci 44:600-607
  146. Childs, JE, Ksiazek TG, Spiropoulou CF, Krebs JW, Morzunov S, Maupin GO, Gage KL, Rollin PE, Sarisky J, Enscore RE, Frey JK, Peters CJ, Nichol ST. Serologic and genetic identification of Peromyscus maniculatus as the primary reservoir for a new hantavirus in the southwestern United States. J Infect Dis 1994; 169:1271-80.
  147. Spiropoulou, CF, Morzunov S, Feldmann H, Sanchez A, Peters CJ, Nichol ST. Genome structure and variability of a virus causing hantavirus pulmonary syndrome. Virology 1994;200:715-723
  148. Shefer AM. Tappero JW. Bresee JS. Peters CJ. Ascher MS. Zaki SR. Jackson RJ. Werner SB. Rollin PE. Ksiazek TG. et al. Hantavirus pulmonary syndrome in California: report of two cases and investigation. Clinical Infectious Diseases. 19:1105-9, 1994
  149. Hjelle, Brian, C.F. Spiropoulou, N Torrez-Martinez, S Morzunov, C.J. Peters, and S.T. Nichol. Detection of Muerto Canyon virus RNA in peripheral blood mononuclear cells from patients with hantavirus pulmonary syndrome. J. Infect Dis, 1994;170:1013-1017
  150. Mills, J.N., B.A. Ellis, J.E. Childs, K.T. McKee, J.I. Maiztegui, C.J. Peters, T.G. Ksiazek, P.B. Jahrling. 1994 Prevalence of infection with Junin virus in rodent populations in the epidemic area of Argentine hemorrhagic fever. Am J Trop Med Hyg 51:554-562
  151. Feldmann H, Nichol ST, Klenk H-D, Peters CJ, Sanchez A. Characterization of filoviruses based on differences in structure and antigenicity of the virion glycoprotein. Virology 1994;199:469-473
  152. Barton, L.L., Budd, S.C., Morfitt, W.S., Peters, C.J., Ksiazek, T.G., Schindler, R.F., and Yoshino, M.T., 1993. Congenital lymphocytic choriomeningitis virus infection in twins. Pediatr Infect Dis J., 12: 942-946
  153. Nichol, S.T., C.F. Spiropoulou, S. Morzunov, Rollin PE, Ksiazek TG, Feldmann H, Sanchez A, Childs J, Zaki S, Peters CJ. Genetic identification of a hantavirus associated with an outbreak of acute respiratory illness. Science 1993; 262:914-17
  154. Simonsen L, Dalton MJ, Breiman RF, Hennessy T, Umland ET, Sewell CM, Rollin PE, Ksiazek TG, Peters CJ. Evaluation of the magnitude of the 1993 hantavirus outbreak in the southwestern United States. J Infect Dis 1995;172:729-733
  155. Tesh, R.B., Wilson M.L., Salas, R., De Manzione, N.M.C., Tovar, D., Ksiazek, T.G., and Peters, C.J., 1993. Field studies on the epidemiology of Venezuelan hemorrhagic fever: implication of the cotton rat Sigmodon alstoni as the probable rodent reservoir. Amer J Trop Med Hyg., 49: 133-141
  156. Feldmann H, Sanchez A, Morzunov S, Spiropoulou CF, Rollin PE, Ksiazek TG, Peters CJ. Nichol ST. Utilization of autopsy RNA for the synthesis of the nucleocapsid antigen of a newly recognized virus associated with hantavirus pulmonary syndrome. Virus Res 1993;30:351-367
  157. Guo, ZM, C Qian, CJ Peters, and CT Liu. 1993. Changes in platelet-activating factor, catecholamine, and serotonin concentrations in brain, cerebrospinal fluid, and plasma of Pichinde virus-infected guinea pigs. Lab Anim Sci. 43:569-574
  158. Kim S, E.T. Kang, YG Kim, JS Han, JS Lee, YI Kim, WC Hall, JM Dalrymple, CJ Peters. Localization of Hantaan viral envelope glycoproteins by monoclonal antibodies in renal tissues from patients with Korean hemorrhagic fever. Amer J. Clin Pathol 1993;100::398-403
  159. Connolly, B.M., Jensen, A.B., Peters, C.J., Geyer, S.J., Barth, J.F., and McPherson, R.A., 1993. Pathogenesis of Pichinde virus infection in strain 13 guinea pigs: an immunocytochemical, virologic, and clinical chemistry study. Am J Trop Med Hyg., 49: 10-24
  160. Hantavirus infection - Southwestern United States: interim recommendations for risk reduction. MMWR RR-11 1993;42:1-12
  161. Krakauer T and Peters, CJ. 1993 Lipopolysaccharide inhibits the production of lymphocytic choriomeningitis virus in human monocytic cell line. J Gen Virol 74:1653-1656
  162. Hayes, C.G., J.P. Burans, T.G. Ksiazek, R.A. Del Rosario, M.E.G. Miranda, C.R. Manaloto, A.B. Barrientos, C.G. Robles, M.M. Dayrit, and C.J. Peters. Outbreak of fatal illness among captive macaques in the Philippines caused by an Ebola-related filovirus. Am. J. Trop. Med. Hyg. 1992;46:664-671
  163. Engler, R.J.M., Mangiafico, J.A, Jahrling, P.B., Ksiazek, T.G., Pedrotti-Kreuger, M, and Peters, C.J. Venezuelan equine encephalitis-specific immunoglobulin responses: live attenuated TC-83 versus inactivated C-84 vaccine. J Med Virol 1992; 38:305-310
  164. Kenyon, R.H, M.K.Rippey, K.T. McKee, P.M.Zack, and C.J. Peters. 1992. Infection of Macaca radiata with viruses of the tick-borne encephalitis group. Microbial Pathogenesis 13:398-409
  165. Qian, C., Ching-Tong, L., and Peters, C.J. 1992. Increased platelet-activating factor (PAF) concentrations in hearts and lungs of Pichinde virus-infected guinea pigs. J Lipid Mediators, 5: 261-270
  166. Ksiazek, T.G., P.E. Rollin, P.B. Jahrling, E. Johnson, D.A. Dalgard, and C.J. Peters. 1992 An enzyme-linked immunosorbent assay for Ebola antigens in the tissues of infected primates J. Clin Micro 30(4):947-950
  167. Kenyon RH. McKee KT Jr. Zack PM. Rippy MK. Vogel AP. York C. Meegan J. Crabbs C. Peters CJ. Aerosol infection of rhesus macaques with Junin virus. Intervirology. 33(1):23-31, 1992
  168. Mills JN, Ellis BA, McKee KT, Calderon GE, Maiztegui JI, Nelson GO, Ksiazek TG, Peters CJ, Childs JE. A longitudinal study of Junin virus activity in the rodent reservoir of Argentine hemorrhagic fever. Am J Trop Med Hyg 1992;47(6):749-763
  169. Guo, Z.M., C.T. Liu, and C.J. Peters. 1992 Possible involvement of endogenous beta-endorphin in the pathophysiological mechanisms of Pichinde virus-infected guinea pigs. Proc. Soc. Exp. Biol. Med., 200:343-348
  170. Qian, C., C.T. Liu, and C.J. Peters. 1992 Metabolism of platelet-activating factor (PAF) in neutrophils isolated from Pichinde virus-infected guinea pigs. J. Leukoc. Biol. 51:210-213
  171. Dalgard, D.W., R.J. Hardy, S.L. Pearson, G.J. Pucak, R.V. Quander, P.M. Zack, C.J. Peters, and P.B. Jahrling. Combined simian hemorrhagic fever and Ebola virus infection in cynomolgus monkeys. Lab. Anim. Sci. 42:152-7, 1992
  172. Morrill, J. C. , C. W. Czarniecki, and C. J. Peters. 1991. Recombinant human inteferon-gamma modulates Rift Valley fever virus infection in the rhesus monkey. J Inteferon Res 11:297-304
  173. Anderson, G.W., Jr., J.A. Rosebrock, A.J. Johnson, G.B. Jennings, and C.J. Peters. 1991. Infection of inbred rat strains with Rift Valley fever virus: development of a congenic resistant strain and observations on age-dependence of resistance. Am. J. Trop. Med. Hyg. 44(5): 475-480
  174. Mills, J.N., B.A. Ellis, K.T. McKee, Jr., T.G. Ksiazek, J.G. Barrera Oro, J.I. Maiztegui, G.E. Calderon, C.J. Peters, and J.E. Childs. 1991. Junin virus activity in rodents from endemic and nonendemic loci in central Argentina. Am. J. Trop. Med. Hyg. 44(6): 589-597
  175. Morrill JC. Carpenter L. Taylor D. Ramsburg HH. Quance J. Peters CJ Further evaluation of a mutagen-attenuated Rift Valley fever vaccine in sheep. Vaccine. 9(1):35-41, 1991
  176. Rollin, P.E., T.G. Ksiazek, P.B. Jahrling, M. Haines, and C.J. Peters. 1991. Detection of Ebola-like viruses by immunofluorescence. Lancet 336: 1591
  177. Peters, C.J., J.W. Huggins, and P.B. Jahrling. 1991. Antiviral therapy for yellow fever. Annals of the International Symposium on Yellow Fever and Dengue, 15-19 May 1988, Rio de Janeiro, Brazil, pp. 134-152
  178. Linthicum, K.J., T.M. Logan, C.L. Bailey, S.W. Gordon, C.J. Peters, T.P. Monath, J. Osorio, D.B. Francy, R.G. McLean, J.W. LeDuc, R.R. Graham, P.B. Jahrling, J.R. Moulton, and D.J. Dohm. 1991. Venezuelan equine encephalomyelitis infection in and transmission by the tick Amblyomma cajennense (Arachnida: Ixodidae). J. Med. Entomol. 28(3): 405-409
  179. Peters, C.J., E.D. Johnson, P.B. Jahrling, T.G. Ksiazek, P.E. Rollin, J. White, W. Hall, R. Trotter, and N. Jaax. 1991. Filoviruses. In Emerging Viruses (S. Morse, ed.). pp 159-75 Oxford University Press, New York
  180. Peters, C.J., P.B. Jahrling, T.G. Ksiazek, and H.W. Lupton. 1991. Filovirus contamination of cell cultures. In Biological Standardization (M. Williams, ed.). (Proceedings of the Cell Substrate Workshop, 20-22 March 1991, Bethesda, Maryland)
  181. Hall, W.C., T.P. Crowell, D.M. Watts, V.L.R. Barros, H. Kruger, F. Pinheiro, and C.J. Peters. Demonstration of yellow fever and dengue antigens in formalin-fixed paraffin-embedded human tissues by immunohistochemistry. Am. J. Trop. Med. Hyg. 1991;45:408-417
  182. Mills, J.N., G.E. Calderon, B.A. Ellis, K.T. McKee, Jr., T.G. Ksiazek, J.G. Barrera Oro, C.J. Peters, J.E. Childs, and J.I. Maiztegui. Nuevas observaciones de la infeccion de roedores por el virus Junin dentro y fuera de la zona endemica de la fiebre hemorragica Argentina. Medicina (Buenos Aires) 1991;51:519-523
  183. Foberg, U., A. Fryden, B. Isaksson, P. Jahrling, A. Johnson, K. McKee, B. Niklasson, B. Normann, C. Peters, and M. Bengtsson. 1991. Viral haemorrhagic fever in Sweden: experiences from management of a case. Scand. J. Infect. Dis. 23: 143-151
  184. Miller, R.K., J.Y. Baumgardner, C.W. Armstrong, S.R. Jenkins, C.D. Woolard, G.B. Miller, Jr., L.D. Polk, D.R. Tavris, K.A. Hendricks, J.P. Taylor, D.M. Simpson, S. Schultz, L. Sturman, J.G. Debbie, D.L. Morse, P.E. Rollin, P.B. Jahrling, T.G. Ksiazek. and C.J. Peters. 1990. Update: Filovirus infection among persons with occupational exposure to nonhuman primates. MMWR 39(16): 266-267 & 273
  185. Jahrling, P.B., T.W. Geisbert, D.W. Dalgard, E.D. Johnson, T.G. Ksiazek, W.C. Hall, and C.J. Peters. 1990. Preliminary report: isolation of Ebola virus from monkeys imported to USA. Lancet 335: 502-505
  186. Miller, R.K., J.Y. Baumgardner, C.W. Armstrong, S.R. Jenkins, C.D. Woolard, G.B. Miller, Jr., P.E. Rollin, P.B. Jahrling, T.G. Ksiazek, and C.J. Peters. 1990. Update: Filovirus infection in animal handlers. MMWR 39(13): 221
  187. Antoniadis A, Alexiou-Daniel S, Malissiovas N, Doutsos J, Polyzoni T, LeDuc JW, Peters CJ, Saviolakis G. Seroepidemiological survey for antibodies to arboviruses in Greece. Arch Virol 1990;Suppp1:277-285
  188. Kenyon, R.H., R.M. Condie, P.B. Jahrling, and C.J. Peters. 1990. Protection of guinea pigs against experimental Argentine hemorrhagic fever by purified human IgG: importance of elimination of infected cells. Microbial Pathogenesis 9: 219-226
  189. Morrill, J.C., G.B. Jennings, A.J. Johnson, T.M. Cosgriff, P.H. Gibbs, and C.J. Peters. 1990. Pathogenesis of Rift Valley fever in rhesus monkeys: Role of interferon response. Arch. Virol. 110: 195-212
  190. Anderson, G.W., Jr., M.V. Slayter, W. Hall, and C.J. Peters. 1990. Pathogenesis of a phleboviral infection (Punta Toro virus) in golden syrian hamsters. Arch.of Virol. 114: 203-212
  191. Sarthou JL. Jouan A. Le Guenno B. Philippe B. Riou O. Lena P. Knauert FK. Peters CJ. Digoutte JP. Isolation of Rift Valley fever virus from human peripheral blood mononuclear cells: Mauritanian epidemic. Research in Virology. 140(3):263-70, 1989
  192. Morrill, J.C., F.K. Knauert, T.G. Ksiazek, J.M. Meegan, and C.J. Peters. 1989. Rift Valley fever infection of rhesus monkeys: implications for rapid diagnosis of human disease. Res. Virol. 140: 139-146
  193. Cosgriff, T.M., J.C. Morrill, G.B. Jennings, L.A. Hodgson, M.V. Slayter, P.H. Gibbs, and C.J. Peters. 1989. The hemostatic derangement produced by Rift Valley fever virus in rhesus monkeys. Rev. Inf. Dis. 11: S807-S814
  194. Peters, C.J., C.-T. Liu, G.W. Anderson, Jr., J.C. Morrill, and P.B. Jahrling. 1989. Pathogenesis of viral hemorrhagic fever: Rift Valley fever and Lassa fever contrasted. Rev. Inf. Dis. 11:S743-S749
  195. Knauert, F.K., J.M. Meegan, A. Jouan, T.G. Ksiazek, B. LeGuenno, J.L. Sarthou, C.J. Peters, and J.P. Digoutte. 1989. Assessment of an rDNA probe filter hybridization assay for the detection of Rift Valley fever virus RNA in human serum samples from the Mauritanian epidemic. Res. Virol. 140: 47-57
  196. Digoutte, J-P, A. Jouan, B. LeGuenno, O. Riou, B. Philippe, J. Meegan, T.G. Ksiazek, and C.J. Peters. 1989. Isolation of the Rift Valley fever virus by inoculation to Aedes pseudoscutellaris cells: comparison with other diagnostic methods. Res. Virol. 140: 31-41
  197. Meegan, J., B. LeGuenno, T. Ksiazek, A. Jouan, F. Knauert, J.P. Digoutte, and C.J. Peters. 1989. Rapid diagnosis of Rift Valley fever: a comparison of methods for the direct detection of viral antigen in human sera. Res. Virol. 140: 59-65
  198. Anderson, G.W., Jr., J.-F. Saluzzo, T.G. Ksiazek, J.F. Smith, W. Ennis, D. Thureen, C.J. Peters, and J.P. Digoutte. 1989. Comparison of in vitro and in vivo systems for propagation of Rift Valley fever virus from clinical specimens. Res. Virol. 140: 129-138
  199. Ksiazek, T.G., A. Jouan, J.M. Meegan, B. LeGuenno, M.L. Wilson, C.J. Peters, J.P. Digoutte, M. Guillaud, N.O. Merzoug, and E.M. Touray. 1989. Rift Valley fever among domestic animals in the recent West African outbreak. Res. Virol. 140: 67-77
  200. Genovesi, E.V., A.J. Johnson, and C.J. Peters. 1989. Delayed type-hypersensitivity response of inbred strains of Syrian golden hamsters (Mesocricetus auratus) to lethal or non-lethal lymphocytic choriomeningitis virus (LCMV) infections. Microbial Pathogenesis 7: 347-360
  201. Watts, D.M., M.A. Ussery, D. Nash, and C.J. Peters. 1989. Inhibition of Crimean-Congo hemorrhagic fever viral infectivity yields in vitro by ribavirin. Am. J. Trop. Med. Hyg. 41: 581-585
  202. Jahrling PB, Geisbert TW, Jaax NK, Hanes MA, Ksiazek TG, and Peters CJ. Experimental infection of cynomolgus macaques with Ebola-Reston filoviruses from the 1989-1990 U.S. epizootic. Arch Virol 1996; [Supp] 11:115-134
  203. Dalgard, D., J.Y. Baumgardner, C.W. Armstrong, S.R. Jenkins, C.D. Woolard, G.B. Miller, Jr., P.B. Jahrling, T.G. Ksiazek, E.D. Johnson, and C.J. Peters. 1989. Ebola virus infection in imported primates - Virginia, 1989. MMWR 38(48):831-832
  204. Mebus, C.A., J.C. Morrill, R.G. Breeze, and C.J. Peters. 1989. Safety and immunogenicity of a mutagen attenuated Rift Valley fever virus in pregnant cattle. Proceedings of the 93rd Annual Meeting of the U.S. Animal Health Association, Las Vegas, Nevada
  205. Peters, CJ, Ennis WE, Turell MJ, and Niklasson BS. 1989. Rapid detection of Rift Valley fever antigen in the serum of infected lambs. Res. Virol. 140: 43-46
  206. Kenyon, R.H., and C.J. Peters. 1989. Actions of complement on Junin virus. Rev. Infect. Dis. 11: S771-S776
  207. Digoutte, J.P., and C.J. Peters. 1989. General aspects of the 1987 Rift Valley fever epidemic in Mauritania. Res. Virol. 140: 27-30
  208. Sanchez, A., Pifat, D.Y., Kenyon, R.H., Peters, C.J., J.B. McCormick, and M.P. Kiley. 1989. Junin virus monoclonal antibodies: characterization and cross-reactivity with other arenaviruses. J. Gen. Virol. 70: 1125-1132
  209. Morrill, J.C., G.B. Jennings, T.M. Cosgriff, P.H. Gibbs, and C.J. Peters. 1989. Prevention of Rift Valley fever in rhesus monkeys with interferon-alpha. Rev. Inf. Dis. 11: S815-S825
  210. Mangiafico, J.A., J.L.Sanchez, L.T. Figueiredo, J.W. LeDuc, and C.J. Peters. 1988. Isolations of a newly recognized Bunyamwera serogroup virus from a febrile human in Panama. Am. J. Trop. Med. Hyg. 39: 593-596
  211. Watts, D.M., C. MacDonald, C. L. Bailey, J.M. Meegan, C.J. Peters, and K.T. McKee, Jr. 1988. Experimental infection of Phlebotomus papatasi with Sandfly fever Sicilian virus. Am. J. Trop. Med. Hyg. 39:611-616
  212. Peters, C.J. 1988. Rift Valley fever update - West Africa. In Foreign Animal Disease Report 16-3, Animal and Plant Health Inspection Service, Department of Agriculture, pp. 7-11
  213. Anderson, G.W., Jr., and C.J. Peters. 1988. Viral determinants of virulence for Rift Valley fever (RVF) in rats. Microbial Pathogenesis 5:241-250
  214. Peters, C.J., D. Jones, R. Trotter, J. Donaldson, J. White, E. Stephen, and T.W. Slone, Jr. 1988. Experimental Rift Valley fever in rhesus macaques. Arch. Virol. 99: 31-44
  215. Kenyon, R.H., D.E. Green, J.I. Maiztegui, and C.J. Peters. 1988. Viral strain dependent differences in experimental Argentine hemorrhagic fever (Junin virus) infection in guinea pigs. Intervirol. 29: 133-143
  216. Anderson, G.W., Jr., T.W. Slone, Jr., and C.J. Peters. 1988. The gerbil, Meriones unguiculatus, a model for Rift Valley fever viral encephalitis. Microbial Pathogenesis 102: 187-196
  217. Genovesi, E.V., A.J. Johnson, and C.J. Peters. 1988. Susceptibility and resistance of inbred strains of Syrian golden hamsters (Mesocricetus auratus) to wasting disease caused by lymphocytic choriomeningitis virus: pathogenesis of lethal and non-lethal infections. J. Gen. Virol. 69: 2209-2220
  218. Lewis, R.M., T.M. Cosgriff, C.J. Peters, and J.C. Morrill. 1987. Differentiation of a human monocytic cell line associated with increased production of Rift Valley fever virus by infected cells. J. Med. Virol. 23: 207-215
  219. Genovesi, E.V. and C.J. Peters. 1987. Immunosuppression-induced susceptibility of inbred hamsters (Mesocricetus auratus) to lethal-disease by lymphocytic choriomeningitis virus infection. Arch. Virol. 97: 61-76
  220. Anderson, G.W., Jr., T.W. Slone, and C.J. Peters. 1987. Pathogenesis of Rift Valley fever virus (RVFV) in inbred rats. Microbial Pathogenesis 2: 283-293
  221. Feinsod, F.M., T.G. Ksiazek, R. McN. Scott, A.K. Soliman, I.H. Farrag, W.H. Ennis, C.J. Peters, and S. El Said. 1987. Sandfly fever-Naples in Egypt. Am. J. Trop. Med. Hyg. 37: 193-196
  222. Niklasson, B., J. Liljestrand, S. Bergstrom, and C. J. Peters. 1987. Rift Valley fever: a sero-epidemiological survey among pregnant women in Mozambique. Epidem. Inf. 99: 517-522
  223. Peters, C.J., P.B. Jahrling, C.T. Liu, R.H. Kenyon, K.T. McKee, Jr., and J.G. Barrera Oro. 1987. Experimental studies of arenaviral hemorrhagic fevers. In Current Topics in Microbiology and Immunology, Vol. 134, Arenaviruses: Epidemiology and Immunotherapy, pp. 5-68 (M.B. Oldstone, ed.). Springer-Verlag, Heidelberg
  224. Genovesi, E.V., and C.J. Peters. 1987. Susceptibility of inbred Syrian hamsters (Mesocricetus auratus) to lethal disease by lymphocyte choriomeningitis virus (42541). Proc. Society Exp. Biol. and Med. 185: 250-261
  225. McKee, K.T., Jr., B.G. Mahlandt, J.I. Maiztegui, D.E. Green, and C.J. Peters. 1987. Virus-specific factors in experimental Argentine hemorrhagic fever in rhesus macaques. J. Med. Virol. 22: 99-111
  226. Meegan, J.M., R.J. Yedloutschnig, B.A. Peleg, J. Shy, C.J. Peters, J.S. Walker, and R.E. Shope. 1987. Enzyme-linked immunosorbent assay for detection of antibodies to Rift Valley fever virus in ovine and bovine sera. Am. J. Vet. Res. 48: 1138-1141
  227. Morrill, J.C., G.B. Jennings, H. Caplen, M.J. Turell, A.J. Johnson, C.J. Peters. 1987. Pathogenecity and immunogenicity of a mutagen-attenuated Rift Valley fever virus immunogen in pregnant ewes. Am. J. Vet. Res. 48: 1042-1047
  228. Peters, C.J., J.A. Reynolds, T.W. Slone, D.E. Jones, and E.L. Stephen. 1986. Prophylaxis of Rift Valley fever with antiviral drugs, immune serum, an interferon inducer, and a macrophage activator. Antiviral Res. 6: 285-297
  229. Allam, I.H., F.M. Feinsod, R.M. Scott, C.J. Peters, A.J. Saah, S.A. Ghaffar, S. El Said, and M.A. Darwish. 1986. Rift Valley fever surveillance in mobile sheep flocks in the Nile Delta, Egypt. Am. J. Trop. Med. Hyg. 35 (5): 1055-1060
  230. Meadors, G.F., III., P.H. Gibbs, and C.J. Peters. 1986. Evaluation of a new Rift Valley fever vaccine: safety and immunogenicity trials. Vaccine 4: 179-184
  231. Kenyon, R.H., and C.J. Peters. 1986. Cytolysis of Junin infected target cells by immune guinea pig spleen cells. Microbial Pathogenesis 1: 453-464
  232. Kenyon, R.H., K.T. McKee, Jr., J.I. Maiztegui, D.E. Green, and C.J. Peters. 1986. Heterogeneity of Junin virus strains. Med. Microbiol. Immunol. 175: 165-167
  233. Jahrling, P.B., and C.J. Peters. 1986. Serology and virulence diversity among Old-World arenaviruses, and the relevance to vaccine development. Med. Microbiol. Immunol. 175: 165-167.
  234. Gonzalez JP, Georges AJ, Kiley MP, Meunier DM, Peters CJ, McCormick JB. Evolutionary biology of a Lassa virus complex. Med Microbiol Immun. 1986;157-159
  235. Liu, C.T., P.B. Jahrling, and C.J. Peters. 1986. Evidence for the involvement of sulfidopeptide leukotrienes in the pathogenesis of Pichinde virus infection in strain 13 guinea pigs. Prostaglandins Leukotrienes Med. 24: 129-138
  236. Scott, R. McN., F.M. Feinsod, I.H. Allam, T. G. Ksiazek, C.J. Peters, B.A.M. Boulos, and M.A. Darwish. 1986. Serological tests for detecting Rift Valley fever viral antibodies in sheep from the Nile Delta. J. Clin. Microbiol. 24: 612-614
  237. Kenyon, R.H., D.E. Green, G.A. Eddy, and C.J. Peters. 1986. Treatment of Junin virus-infected guinea pigs with immune serum: Development of late neurological disease. J. Med. Virol. 20: 207-218
  238. Kenyon, R.H., P.G. Canonico, D.E. Green, and C.J. Peters. 1986. Effect of ribavirin and tributylribavirin on Argentine hemorrhagic fever (Junin virus) in guinea pigs. Antimicrob. Agents Chemother. 29: 521-523
  239. Caplen, H.C., C.J. Peters, and D.H.L. Bishop. 1985. Mutagen directed attenuation of Rift Valley fever virus as a method for vaccine development. J. Gen. Virol. 66: 2271-2277
  240. McKee, K.T., G.R. Kim, D.E. Green, and C.J. Peters. 1985. Hantaan virus infection in suckling mice: Virologic and pathologic correlates. J. Med. Virol. 17: 107-117
  241. McKee, K., C. MacDonald, J.W. LeDuc, and C.J. Peters. 1985. Hemorrhagic fever with renal syndrome - A clinical perspective. Mil. Med. 150: 640-647
  242. Kenyon, R.H., D.E. Green, and C.J. Peters. 1985. Effect of immuno-suppression on experimental Argentine hemorrhagic fever in guinea pigs. J. Virol. 53: 75-80
  243. Niklasson, B.S., M.J. Dobersen, C.J. Peters, W.H. Ennis, and E. Moller. 1985. An outbreak of Coxsackievirus B infection followed by one case of diabetes mellitus. Scand. J. Infect. Dis. 17: 15-18
  244. Ehrnst, A., C.J. Peters, B. Niklasson, A. Svedmyr, and B. Holmgren. 1985. Neurovirulent Toscana virus (A Sandfly fever virus) in Swedish man after visit to Portugal. Lancet, May 25 (Letter)
  245. Niklasson, B., C.J. Peters, E. Bengtsson, and E. Norrby. 1985. Rift Valley fever virus vaccine trial: study of neutralizing antibody response in humans. Vaccine 3: 123-127
  246. McKee, K.T., D.E. Green, B.G. Mahlandt, L.R. Bagley, W.H. Lyerly, Jr., C.J. Peters, and G.A. Eddy. 1985. Infection of Cebus monkeys with Junin virus. Medicina 45 (2): 144-152
  247. McKee, K.T., B.G. Mahlandt, J.I. Maiztegui, G.A. Eddy, and C.J. Peters. 1985. Experimental Argentine hemorrhagic fever in rhesus macaques: viral strain-dependent clinical response. J. Infect. Dis. 152 (1): 218-221
  248. Kark, J.D., Y. Aynor, and C.J. Peters. 1985. A Rift Valley fever vaccine trial: 2. Serological response to booster doses with a comparison of intradermal versus subcutaneous injection. Vaccine 3: 117-122
  249. Niklasson, B., C.J. Peters, M. Grandien, and O. Wood. 1984. Detection of human immunoglobulins G and M antibodies to Rift Valley fever virus by enzyme-linked immunosorbent assay. J. Clin. Microbiol. 19: 225-229
  250. Antoniadis, A., M. Pyrpasopoulos, M. Sion, S. Daniel, and C.J. Peters. 1984. Two cases of hemorrhagic fever with renal syndrome in northern Greece. J. Infect. Dis. 149: 1011-1013
  251. Niklasson, B.S., P.B. Jahrling, and C.J. Peters. 1984. Detection of Lassa virus antigens and Lassa virus-specific immunoglobulins G and M by enzyme-linked immunosorbent assay. J. Clin. Microbiol. 20: 239-244
  252. Niklasson, B.S., G.F. Meadors, and C.J. Peters. 1984. Active and passive immunization against Rift Valley fever virus infection in Syrian hamsters. Acta Path. Microbiol. Immunol. Scand. Sect. C. 92: 197-200
  253. Jahrling, P.B., C.J. Peters, and E.L. Stephen. 1984. Enhanced treatment of Lassa fever by immune plasma combined with ribavirin in cynomolgus monkeys. J. Infect. Dis. 149: 420-427
  254. Jahrling, P.B. and C.J. Peters. 1984. Passive antibody therapy of Lassa fever in cynomolgus monkeys: Importance of neutralizing antibody and Lassa virus strain. Infect. Immun. 44: 528-533
  255. Meegan, J.M., J.P. Digoutte, C.J. Peters, and R.E. Shope. 1983. Monoclonal antibodies to identify Zinga virus as Rift Valley fever virus. Lancet 1: 641 (Letter)
  256. Niklasson, B., M. Grandien, C.J. Peters, and T.P. Gargan II. 1983. Detection of Rift Valley fever virus antigen by enzyme-linked immunosorbent assay. J. Clin. Microbiol. 17: 1026-1031
  257. Lupton, H.W., C.J. Peters, and G.A. Eddy. 1983. Rift Valley fever: global spread or global control?, pp. 261-275. In Proceedings of the 86th Annual Meeting of the U.S. Animal Health Association
  258. Zaki SR. Albers RC. Greer PW. Coffield LM. Armstrong LR. Khan AS. Khabbaz R. Peters CJ. Retrospective diagnosis of a 1983 case of fatal hantavirus pulmonary syndrome [letter].Lancet. 343:1037-8, 1994
  259. Georges, A.J., S.A. Wahid, D.Y.M. Meunier, M.C. Georges, J.F. Saluzzo, C.J. Peters, J.B. McCormick, and J.P. Gonzalez. 1983. Serological equivalence of endemic Zinga virus and Rift Valley fever virus in Central African Republic. Lancet 1: 1338 (Letter)
  260. Tesh, R.B., C.J. Peters, and J.M. Meegan. 1982. Studies on the antigenic relationship among Phleboviruses. Am. J. Trop. Med. Hyg. 31: 149-155
  261. Shope, R.E., C.J. Peters, and F.G. Davies. 1982. The spread of Rift Valley fever and approaches to its control. Bull. WHO 60: 299-304
  262. Kark, J.D., Y. Aynor, and C.J. Peters. 1982. A Rift Valley fever vaccine trial. I. Side effects and serologic response over a six-month follow-up. Am. J. Epidemiol. 116: 808-820
  263. Kark, J.D., Y. Aynor, Y. Ben Mordechai, N. Ron-Kuper, B.A. Peleg, and C.J. Peters. 1982. A serological survey of Rift Valley fever antibodies in the northern Sinai. Trans. R. Soc. Trop. Med. Hyg. 76: 427-430
  264. Peters, C.J., K.M. Johnson, W.C. Reeves. 1982. Hepatitis B in families. Ann. Int. Med. 97: 787 (Letter)
  265. Peters, C.J., and T.W. Slone. 1982. Inbred rat strains mimic the disparate human response to Rift Valley fever. J. Med. Virol. 10: 45-54
  266. Eddy, G.A., C.J. Peters, G. Meadors, and F.E. Cole, Jr. 1981. Rift Valley fever vaccine for humans, pp. 124-141. In Contributions to Epidemiology and Statistics, vol. 3 (N. Goldblum, T.A. Swartz, and M. A. Klingberg, eds.). Karger, Basel
  267. Peters, C.J., and G.W. Anderson. 1981. Pathogenesis of Rift Valley fever, pp. 21-41. In Contributions to Epidemiology and Statistics, vol. 3 (N. Goldblum, T.A. Swartz, and M.A. Klingberg, eds.). S. Karger, Basel
  268. Shope, R.E., J.M. Meegan, C.J. Peters, R. Tesh, A.A. Travassos da Rosa. 1981. Immunologic status of Rift Valley fever virus, pp. 42-52. In Contributions to Epidemiology and Statistics, vol. 3 (N. Goldblum, T.A. Swartz, and M.A. Klingberg, eds.). S. Karger, Basel
  269. Compans, R.W., D.P. Boersma, P. Cash, J.P.M. Clerx, H.B. Gimenez, W.E. Kirk, C.J. Peters, A.C. Vezza, and D.H.L. Bishop. 1981. Molecular and genetic studies of Tacaribe, Pichinde, and lymphocytic choriomeningitis viruses, pp. 31-42. In The Replication of Negative Strand Viruses. (D H.L. Bishop and R.W. Compans, eds.). Elsevier, Amsterdam
  270. Yedloutschnig, R.J., A.H. Dardiri, J.S. Walker, C.J. Peters, and G.A. Eddy. 1981. Response of pregnant Hereford cattle to a formalinized Rift Valley fever vaccine, pp. 530-539. In XI International Congress of Diseases of Cattle (E. Mayer, ed.). Bregman Press, Haifa, Israel
  271. Dalrymple, J.M., C.J. Peters, J.F. Smith, and M.K. Gentry. 1981. Antigenic components of Punta Toro virus, pp. 167-172. In The Replication of Negative Strand Viruses (D.H.L. Bishop and R.W. Compans, eds.). Elsevier, Amsterdam
  272. Peters, C.J. 1981. Seven murine cell lines with properties of macrophages. J. Reticuloendothel. Soc. 30: 453-470
  273. Peters, C.J., C.L. Bailey, and G.A. Eddy. 1981. Current Rift Valley fever research: potential implications for the Middle East. J. Egypt. Public Health Assoc. 56: 384-402
  274. Stephen, E.L., D.E. Jones, C.J. Peters, G.A. Eddy, P.S. Loizeaux, and P.B. Jahrling. 1980. Ribavirin treatment of toga-, arena-, and bunyavirus infections in subhuman primates and other laboratory animal species, pp. 169-183. In Ribavirin: A Broad Spectrum Antiviral Agent, Academic Press, New York, ed Smith, RA and Kirkpatrick W
  275. Reynolds, J.A., D.G. Harrington, C.L. Crabbs, C.J. Peters, and N.R. Di Luzio. 1980. Adjuvant activity of a novel metabolizable lipid emulsion with inactivated viral vaccines. Infect. Immun. 28: 937-943.
  276. Eisenberg, R.A., S. Izui, P.J. McConahey, L. Hang, C.J. Peters, A.N. Theofilopoulos, and F.J. Dixon. 1980. Male determined accelerated autoimmune disease in BXSB mice: transfer by bone marrow and spleen cells. J. Immunol. 125: 1032-1036
  277. Kirk, W.E., P. Cash, C.J. Peters, and D.H.L. Bishop. 1980. Formation and characterization of an intertypic lymphocytic choriomeningitis recombinant virus. J. Gen. Virol. 51: 213-218
  278. Reynolds, J.A., M.D. Kastello, D.G. Harrington, C.L. Crabbs, C.J. Peters, J.V. Jemski, G.H. Scott, and N.R. Di Luzio. 1980. Glucan-induced enhancement of host resistance to selected infectious diseases. Infect. Immun. 30: 51-57
  279. Shope, R.E., C.J. Peters, and J.S. Walker. 1980. Serologic relationship between Rift Valley fever virus and viruses of the phlebotomus fever serogroup. Lancet 1: 886-887 (Letter)
  280. Eddy, G.A., and C.J. Peters. 1980. The extended horizons of Rift Valley fever: current and projected immunogens, pp. 179-191. In Progress in Clinical and Biological Research (A. Mizrahi, I. Hertman, M.A. Klingberg, and A. Kohn, eds.). Alan R. Liss, New York
  281. Harrington, D.G., H.W. Lupton, C.L. Crabbs, C.J. Peters, J.A. Reynolds, and T.W. Slone. 1980. Evaluation of a formalin-inactivated Rift Valley fever vaccine in sheep. Am. J. Vet. Res. 41: 1559-1564.
  282. Yedloutschnig, R.J., A.H. Dardiri, J.S. Walker, C.J. Peters, and G.A. Eddy. 1979. Immune response of steers, goats, and sheep to inactivated Rift Valley fever vaccine, pp. 253-260. In Proceedings of the 83rd Annual Meeting of the U.S. Animal Health Association.
  283. Eisenberg, R.A., A.N. Theofilopoulos, B.S. Andrews, C.J. Peters, L. Thor, and F.J. Dixon. 1979. Natural thymocytotoxic autoantibodies in autoimmune and normal mice. J. Immunol. 122: 2272-2278
  284. Andrews, B.S., A.N. Theofilopoulos, C.J. Peters, D.J. Loskutoff, W.E. Brandt, and F.J. Dixon. 1978. Replication of dengue and Junin viruses in cultured rabbit and human endothelial cells. Infect. Immun. 20: 776-781
  285. Dunne JV. Peters CJ. Moore TL. Vaughan JH. Differential effects of propranolol on lymphocyte rosette formation and response to plant mitogens. Arthritis & Rheumatism. 21(7):767-73, 1978
  286. Peters, C.J., and A.N. Theofilopoulos. 1977. Antibody-dependent cellular cytotoxicity against murine leukemia viral antigens: studies with human lymphoblastoid cell lines and human peripheral lymphocytes as effector cells comparing rabbit, goat, and mouse antisera. J. Immunol. 119: 1089-1096
  287. Peters, C.J., W.C. Reeves, and R.H. Purcell. 1977. Disparate response of monozygotic twins to hepatitis B virus infection. J. Pediatr. 91: 265-266
  288. Reeves, W.C., and C.J. Peters. 1976. The seroepidemiology of reovirus, coxsackievirus B, and hepatitis B virus infections among Panamanian Indian children. J. Infect. Dis. 133: 268-273
  289. Peters, C.J., R.H. Purcell, J.J. Lander, and K.M. Johnson. 1976. Radioimmunoassay for antibody to hepatitis B surface antigen shows transmission of hepatitis B among household contacts. J. Infect. Dis. 134: 218-223
  290. Dietz, Jr., W.H., O. Porcell, T.E. Moon, C.J. Peters, and R.H. Purcell. 1976. IgM levels and IgM-mediated immune responses in patients with acute hepatitis A, acute hepatitis B, and chronic HB antigenaemia. Clin. Exp. Immunol. 23: 69-72
  291. Reeves, W.C., C.J. Peters, and R.H. Purcell. 1975. The epidemiology of hepatitis B antigen and antibody among Panamanian Cuna Indians. Am. J. Trop. Med. Hyg. 24: 873-875
  292. Reeves, W.C., C.J. Peters, T.E. Moon, and R.H. Purcell. 1975. Familial clustering of hepatitis B surface antigen among Panamanian Indians. J. Infect. Dis. 131: 67-70
  293. Peters, C.J., W.C. Reeves, P.V. Holland, and H.J. Alter. 1974. Antigenic subtypes of hepatitis B antigen in Panama. Am. J. Epidemiol. 99: 375-380
  294. Peters, C.J., R.W. Kuehne, R. Mercado, R.H. Le Bow, R.O. Spertzel, and P.A. Webb. 1974. Hemorrhagic fever in Cochabamba, Bolivia, 1971. Am. J. Epidemiol. 99: 425-433
  295. Peters, C.J., W.C. Reeves, V. Rivera, and K.M. Johnson. 1973. Epidemiology of hepatitis B antigen in Panama. Am. J. Epidemiol. 98: 301-310.
  296. Reeves, W.C., C.J. Peters, J.J. Lander, R.H. Purcell, and K.M. Johnson. 1973. Differences in the prevalence of hepatitis B antigen and antibody among Panamanian Indian populations. J. Infect. Dis. 128: 265-270
  297. Webb, P.A., K.M. Johnson, C.J. Peters, and G. Justines. 1973. Behavior of Machupo and Latino viruses in Calomys callosus from two geographic areas of Bolivia, pp. 313-322. In Lymphocytic Choriomeningitis Virus and other Arenaviruses (F. Lehmann-Grube, ed.). Springer-Verlag, Berlin
  298. Peters, C.J., P.A. Webb, and K.M. Johnson. 1972. Measurement of antibodies to Machupo virus by the indirect fluorescent technique. Proc. Soc. Exp. Biol. Med. 142: 526-531
  299. Peters, C.J., and K.M. Johnson. 1972. Serum immunoglobulin levels in Australia antigen positive and Australia antigen negative hepatitis. Clin. Exp. Immunol. 11: 381-391
  300. Rowe, W.P., W.E. Pugh, P.A. Webb, and C.J. Peters. 1970. Serological relationship of the Tacaribe complex of viruses to lymphocytic choriomeningitis virus. J. Virol. 5: 289-292
  301. Peters, C.J., and M. Walser. 1966. Transport of cations by rabbit gall bladder: evidence suggesting a common cation pump. Am. J. Physiol. 210: 677-683
  302. Peters, C.J., and M. Walser. 1966. Transport of cations by rabbit gall bladder: evidence suggesting a common cation pump. Am. J. Physiol. 210: 677-683
  303. Peters, C.J., and K.M. Johnson. April 1970. Hepatitis and Australia antigen in Panama and the Canal Zone, pp. 1-20. In Proceedings of the Military Medical Conference of the Americas, Canal Zone

Search PubMed database for Clarence Peters